Effects of Methylphenidate on Cognitive Function and Gait in Patients With Parkinson's Disease

Authors:
  • JHJeffrey M. Hausdorff
    Jeffrey M. Hausdorff
  • THTalia Herman
    Talia Herman
  • ESEly S. Simon
    Ely S. Simon
  • NGNir Giladi
    Nir Giladi

Abstract
Twenty-one patients with Parkinson's disease were studied before and 2 h after the administration of a single dose of 20 mg of methylphenidate. In response to methylphenidate, attention significantly improved, whereas memory and visual-spatial performance were unchanged. Gait speed, stride time variability, and Timed Up and Go times (demonstrated measures of fall risk) significantly improved. These findings suggest a new potential pharmacologic means of enhancing mobility and decreasing fall risk in Parkinson's disease.

This publication has 9 references indexed in Scilit: